Clinical trials
Amblyopia trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
105 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 4 |
| 2014 | 6 |
| 2015 | 4 |
| 2016 | 7 |
| 2017 | 6 |
| 2018 | 4 |
| 2019 | 10 |
| 2020 | 6 |
| 2021 | 8 |
| 2022 | 6 |
| 2023 | 11 |
| 2024 | 9 |
| 2025 | 6 |
| 2026 | 11 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 43 |
| Recruiting | 18 |
| Unknown status | 18 |
| Not yet recruiting | 8 |
| Terminated | 7 |
| Withdrawn | 7 |
| Active, not recruiting | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Retina Foundation of the Southwest | 6 |
| Universitat Politècnica de Catalunya | 4 |
| Boston Children's Hospital | 3 |
| Erasmus Medical Center | 3 |
| Jaeb Center for Health Research | 3 |
| NovaSight | 3 |
| Amany Refaat Mohamed Abdel Wahid | 2 |
| Beijing Airdoc Technology Co., Ltd. | 2 |
| Cairo University | 2 |
| Centre for Eye and Vision Research | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amblyopia | 105 |
| Strabismus | 15 |
| Anisometropia | 13 |
| Refractive Errors | 5 |
| Myopia | 4 |
| Hyperopia | 3 |
| Bites and Stings | 2 |
| Vision Disorders | 2 |
| Alzheimer Disease | 1 |
| Astigmatism | 1 |
Trials
Showing 51 to 75 of 105. Each trial links to its page on Pharma Observatory.
5 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.